AZoLifeSciences on MSN7h
What are Nucleoside Analogs?
Nucleoside analogs are transformative in cancer and antiviral therapies, offering new avenues for treatment despite ...
Digging into a decades-old hepatitis B mystery suggests a new potential treatment
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
News Medical on MSN3h
Breakthrough discovery unveils potential treatment for hepatitis B
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
GEN2h
HBV’s Ability to Infect Human Liver Cells Thwarted by Potential Anticancer Drug
Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...
GlobalData on MSN9h
Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBV
The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.
Dynavax under fire as investor targets vaccine maker’s board
Deep Track, a Greenwich, Ct., investment management company that holds 13.5% of Dynavax's stock, pointed its finger at ...